Epidiolex®, a cannabidiol (CBD) oral solution by Greenwich Biosciences, is now indicated for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) or Tuberous Sclerosis Complex in patients one year of age or older. Read more about this development in Drug Topics. Learn More      

Read Full Post

In January 2020 the World Health Organization (WHO) declared the outbreak in China of a new coronavirus disease, COVID-19, to be a Public Health Emergency of International Concern. WHO stated that there was a high risk of COVID-19 spreading to other countries around the world. In March 2020, WHO made the assessment that COVID-19 could […]

Read Full Post

The emerging circumstances surrounding the spread of coronavirus disease 2019 (COVID-19) are evolving rapidly. Please stay informed by visiting the CDC’s COVID-19 page regularly. We care deeply about the well-being of our community, and we urge everyone to follow best practices as outlined by their local officials to stay safe and healthy during this time.

Read Full Post

NEWS RELEASE February 2020 International Epilepsy Day marked around the world! International Epilepsy Day is a global event celebrated annually on the second Monday in February, to promote awareness of epilepsy around the world. This year it takes place on Monday, February 10th. Epilepsy is a neurological disorder which affects the brain. It is a tendency […]

Read Full Post

New Orleans, LA, January 14, 2020 — The Epilepsy Alliance America (EAA), a national organization dedicated to providing direct support, care, and service to people living with epilepsy and their families is seeking immediate financial donations to help purchase essential anti-seizure medications for epilepsy patients impacted by the recent 6.4-magnitude earthquake that killed one person, injured […]

Read Full Post

Ella the Jellyfish Brings Comfort and Support to Children with LGS as well as their Families and Caregivers WOODCLIFF LAKE, NJ, November 12, 2019 /PRNewswire/ — Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., today announced the launch of Ella the Jellyfish, the first Amazon Alexa skill designed for those affected by Lennox-Gastaut Syndrome […]

Read Full Post

Pangyo, Gyeonggi Province, Korea and Paramus, New Jersey, USA, November 21, 2019 – SK Biopharmaceuticals, Co., Ltd., an innovative global pharmaceutical company focused on developing and bringing treatments to market for central nervous system (CNS) disorders, and its U.S. subsidiary SK Life Science, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved […]

Read Full Post

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, honors National Epilepsy Awareness Month in the United States this November. The company is working to bring more awareness to epilepsy, the fourth most common neurological disorder impacting more than 65 million people of all ages around the world. Read The Full Story

Read Full Post

Governor Wanda Vázquez Garced proclaimed this Friday the month of November as Month of Awareness and Rehabilitation of People with Epilepsy because the executive mansion lit up violet. Read Full Story (Español) Here

Read Full Post

From Chicago Suntimes: “Miguel and Kelly Cervantes continue to work to help other families and raise money for epilepsy research, as their 4-year-old daughter enters hospice care.” Read The Full Story

Read Full Post